CYCLERION THERAPEUTICS, INC. Proceeds from Contributed Capital
CYCLERION THERAPEUTICS, INC. (CYCN) reported Proceeds from Contributed Capital of $46.44 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-02-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2021-02-25
- CYCLERION THERAPEUTICS, INC. proceeds from contributed capital for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. proceeds from contributed capital for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. proceeds from contributed capital for the quarter ending 2019-06-30 was $10.35M, a 54.82% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. proceeds from contributed capital for the quarter ending 2019-03-31 was $36.09M, a 35.70% increase year-over-year.
- CYCLERION THERAPEUTICS, INC. proceeds from contributed capital for fiscal 2019 was $46.44M, a 53.99% decline from fiscal 2018.
- CYCLERION THERAPEUTICS, INC. proceeds from contributed capital for fiscal 2018 was $100.94M.
| Period end | Proceeds from Contributed Capital 3 month | Proceeds from Contributed Capital 6 month | Proceeds from Contributed Capital 9 month | Proceeds from Contributed Capital 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $10.35M derived: sum of 3 quarters · filed 2021-02-25 | $46.44M 10-K · filed 2021-02-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $10.35M derived: sum of 2 quarters · filed 2020-11-05 | $46.44M 10-Q · filed 2020-11-05 | $71.41M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $10.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $46.44M 10-Q · filed 2020-08-03 | $71.41M derived: sum of 3 quarters · filed 2020-08-03 | $97.87M derived: sum of 4 quarters · filed 2020-08-03 |
| 2019-03-31 | $36.09M 10-Q · filed 2020-05-04 | $61.05M derived: sum of 2 quarters · filed 2020-05-04 | $87.52M derived: sum of 3 quarters · filed 2020-05-04 | $110.44M derived: sum of 4 quarters · filed 2020-05-04 |
| 2018-12-31 | $24.97M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $51.43M derived: sum of 2 quarters · filed 2020-03-12 | $74.35M derived: sum of 3 quarters · filed 2020-03-12 | $100.94M 10-K · filed 2020-03-12 |
| 2018-09-30 | $26.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $49.38M derived: sum of 2 quarters · filed 2019-11-12 | $75.97M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $22.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $49.51M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $26.59M 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |